Abstract
MAP2K3 protein is mitogen-activated protein kinase belonging to the family of kinases involved in intracellular cell proliferation. The mammalian MAPK family that consists of ERK, p38 and JNK signalling pathway is showing a critical role in the regulation of cell proliferation. MAP2K3 and MAP2K6 are highly selective for p38 MAPKs which actively participate at check point controls and various stages of cell cycle at G0, G1/S and G2/M transitions by differential regulation of specific cyclin A or D1. In the present work, the 3D model of MAP2K3 protein is generated using comparative homology modelling techniques, minimized and validated. Active site of the protein is determined using various server tools and literature studies, for the prediction of important binding pockets to identify the putative active site. Virtual screening was carried out using chalcone library in Schrodinger suite to identify new lead molecules to knock down MAP2K3 target protein and inhibit cell proliferation. An Atomistic MD simulation of screened compound with MAP2K3 not only strengthens our findings but also identified the key interactions involved in protein-ligand complex in the dynamic environment.
Similar content being viewed by others
Abbreviations
- NAMD:
-
Nanoscale molecular dynamics
- PDB:
-
Protein Data Bank
- CASTp:
-
Computed Atlas of surface topography of proteins
- ProSA:
-
Protein structure analysis
- OPLS:
-
Optimized potentials for liquid simulations
- MMGBSA:
-
Molecular mechanics generalized born surface area
- RMSD:
-
Root mean square deviation
- SAVES:
-
Structural analysis and verification server
- ADME:
-
Absorption distribution metabolism and excretion
- MD:
-
Molecular dynamics
References
Chang L, Karin M (2001) Mammalian MAP kinase signalling cascades. Nature 410:37–40
Aymone G, Giuseppe S, Giuseppe N et al (2010) Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function. J Biol Chem 19:14160–14169
Cuevas BD, Abell AN, Johnson GL (2009) Role of mitogen -activated protein kinase kinase kinases in signal integration. Oncogene 26:3159–3171
Eun KK, Choi EJ (2010) Pathological roles of MAPK signalling pathways in human diseases. Biochim Biophys Acta 1802:396–405
Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4:937–947
Hari K, Pal M, Koul S (2013) Role of p38 MAP kinase signal transduction in solid tumors. Genes cancer 4:342–359
Chen L, Mayer JA, Krisko TI et al (2009) Inhibition of the p38 kinase suppresses the proliferation human ER-negative breast cancer cells. Cancer Res 69:8853–8861
Dhillon AS, Hagan S, Rath O et al (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279–3290
Cuenda A, Rousseau S (2007) p38 MAP-Kinases pathway regulation, function and role. Biochim Biophys Acta 1773:1358–1375
Bradham C, McClay D (2006) p38 MAPK in development and cancer. Cell Cycle 5:824–828
Chen L, Mayer JA, Krisko TI et al (2009) Inhibition of the p38 Kinase suppresses the proliferation of human ER –negative breast cancer cells. Cancer Research Res 69:8853–8861
Grivennikov SI, Greten FR et al (2010) Immunity, inflammation, and cancer. Cell 140:883–899
James A, McCubrey LS, Steelman A et al (2007) Role of the Raf/ MEK/ ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773:1263–1284
Regad T (2015) Targeting RTK signaling pathways in cancer. Cancers (Basel) 7:1758–1784
Chang –Liang Xu, Shuang –Shuang Zhao, Hong –Wei He et al (2014) synthesis and cytotoxic evaluation of alkoxylated chalcones. Molecules 19:17256-17278
Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9–18
Bhargavi M, Sivan SK, Potlapally SR (2017) Identification of novel anti-cancer agents by applying insilico methods for inhibition of TSPO protein. Comput Biol Chem 68:43–55
Malkhed V, Mustyala KK, Potlapally SR et al (2012) Modelling of alternate RNA polymerase sigma D factor and identification of novel inhibitors by virtual screening. Cell Mol Bioeng 5:363–374
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680
Malkhed V, Gudlur B, Kondagari B et al (2011) Study of interactions between mycobacterium tuberculosis proteins: SigK and anti-SigK. J Mol Model 17:1109–1119
Sali A, Potterton L, Yuan F et al (1995) Evaluation of comparative protein modelling by MODELLER. Proteins 23:318–326
Alice QZ, Corey SO, Lynne R (2011) Revisiting the Ramachandran plot from a new angle. Protein Sci 20:1166–1171
Wiederstein M, Sippl MJ (2007) Prosa-web: interactive web service for recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:407–410
Dundas J, Ouyang Z, Tseng J et al (2006) Castp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34:116–118
Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377–389
Sarita Rajender P, Kiran Kumar M, Vasavi M et al (2012) Novel inhibitors targeting cell signalling receptor-cyclin D2 by virtual screening. J Pharm Res 5:572–579
Roman AL (2001) PDBsum: summaries and analyses of PDB structures. Nucleic Acids Res 29:221–222
Weizhong L, Andrew C, Mahmut U et al (2015) The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic Acids Res 43:580–584
Natesh S, Ludovic C, Bruno OV (2020) Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace. Brief Bioinform:1–29
Chen IJ, Foloppe N (2010) Drug-like bioactive structures and conformational coverage dwith the Ligprep/confgen suite: Comparison to programs MOE and catalyst. J Chem Inf Model 50:822–839
Ghosh S, Nice A, An J et al (2006) Structure based virtual screening of chemical libraries fordrug discovery. Curr Opin Chem Biol 10:194–202
Tian-Yang S, Qi W, Jin Z et al (2013) Trastuzumab-peptide interactions: mechanism and application in structure-based ligand design. Int J Mol Sci 14:16836–16850
Chandra N, Kumari MK, Sharma C, Vijjulatha M et al (2015) QM/MM docking strategy and prime/MM-GBSA calculation of celecoxib analogues as N-myristoyltransferase inhibitors. Virol-mycol 4:141–148
Qikprop version 2.3, Schrodinger, LLC, New York, NY, 2005
Mark James A, Teemu M, Roland S et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX:19–25
Martin S, Bertrand C, Koen M et al (2018) Automated topology builder version 3.0: prediction of salvation free enthalpies in water and hexane. J Chem Theory Comput 14:5834–5845
Nathan S, Andreas P. Alexandra C et al (2011) Definition and testing of the GROMOS force –field versions 54A7 and 54B7n. Eur Biophys J 40:843-856
Katarzyna B, Martin S, Alpeshkumar K, Alan E (2014) Testing and validation of the automated topology builder (ATB) version 2.0: prediction of hydration free enthalpies. J Comput Aided Mol Des 28:221–233
Dymnikov AD, Limar VV, Sidorov VP (1992) Mathematical simulation of precision scanning by a H- beam. AIP conference proceedings 287:658–671
Giovanni B, Davide D, Michele P (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101–014107
Ulrich E, Lalith P, Max LB et al (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577–8593
Berk H, Henk B, Herman JC et al (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1–14
Shuichi M, Peter AK (1992) Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13:952–962
Wenjie D, David CN, Gerald H et al (2007) ViroBLAST: a stand-alone BLAST web server for flexible queries of multiple databases and user’s datasets. Bioinformatics 23:2334–2336
Christian C, Jonathan DB, Geoffrey JB (2008) The Jpred 3 secondary structure prediction server. Nucleic Acids Reas 36:197–201
Lawrence AK, Stefans M, Christipher M et al (2015) The Phyre2 web portal for protein modelling. Nat Protoc 10:845–858
Goverdhan M, Park JH, Praburaman et al (2015) Relative expression of low molecular weight, tyrosine phosphatase (Wzb Gene) of Herbaspirilliumsp GW 103 toward Arsenic stress and molecular modeling. Curr Microbiol l71:311–316
Elham OM, Ahmad B (2013) Correctness and accuracy of template-based modelled single chain fragment variable (scFv) protein anti-breast cancer cell line (MCF-7). O J Gen 3:183–194
Weiqing R, Xiao-Ping W (2000) An iterative grid redistribution method for singular problems in multiple dimensions. J Comput Phys 159:246–273
Sunghwan K, Paul AT, Tiejun C et al (2016) Literature information in PubChem: associations between PubChem records and scientific articles. J Chem Inform 8:32–47
Devjani IB, Tejas PG (2016) Interaction of antimicrobial peptide with mycolyl transferase in Mycobacterium tuberculosis. Int J Mycobactereriol 5:83–88
Ramakrishna D, Ramasree D, Bhargavi K et al (2016) Suppressor of cytokine signalling-3 as a drug target for type 2 diabetes mellitus: a structure-guided approach. J Med Chem Drug Discov 1:2502–2514
Acknowledgement
The author Manan Bhargavi is thankful to the Principal and Head, Department of Chemistry, University College of Science and Nizam College, Osmania University, for providing the facilities to carry out the research work. AJ acknowledges the Department of Biotechnology, Govt of India, for the Ramalingamswami Re-entry Fellowship-2019 and the Birla Institute of Technology Mesra, Ranchi, India, for providing the facilities to carry out the research work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bhargavi, M., Vhora, N., Lanka, G. et al. Homology modelling and virtual screening to explore potent inhibitors for MAP2K3 protein. Struct Chem 32, 1039–1051 (2021). https://doi.org/10.1007/s11224-020-01667-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-020-01667-w